• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

参与大鼠和人类去甲肾上腺素转运体药理学特性差异的氨基酸。

Amino acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters.

作者信息

Paczkowski Filip A, Bryan-Lluka Lesley J

机构信息

Department of Physiology and Pharmacology, School of Biomedical Sciences, The University of Queensland, Brisbane 4072, Queensland, Australia.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 2002 Apr;365(4):312-7. doi: 10.1007/s00210-002-0528-z. Epub 2002 Feb 20.

DOI:10.1007/s00210-002-0528-z
PMID:11919656
Abstract

It has been suggested from a previous study in our laboratory that differences in the pharmacology of the species variants of the noradrenaline transporter (NET) are the result of four non-conservative amino acid exchanges from the total of 26 amino acids that are divergent between the rat NET (rNET) and human NET (hNET). The aim of this study was to examine the effects of changing the rNET at each of these four amino acid residues, which markedly alter local charge distribution, to the amino acid found in hNET.Site-directed mutagenesis was used to create mutant cDNAs from rNET cDNA. The mutant NETs (rK7D, rE62K, rK375N and rR612Q), rNET and hNET were expressed in transiently transfected COS-7 cells to determine the effects of the mutations on the differing pharmacological properties of the species variants. The ratios of V(max) for noradrenaline uptake and B(max) for nisoxetine binding (which are a measure of the turnover number of the transporter, i.e. the number of transport cycles per min) were greater for rNET and rR612Q than for hNET, rK7D, rE62K and rK375N. The K(m) of noradrenaline was lower for hNET, rK7D, rE62K and rK375N than for rNET or rR612Q. There were no differences between the K(i) values for inhibition of noradrenaline uptake by nisoxetine for rNET, hNET or the mutants, but the K(i) values of cocaine were lower for hNET, rE62K and rR612Q than rNET or rK375N.Hence, the study showed that: (1) the aspartate 7, lysine 62 and asparagine 375 amino acid residues are important in determining the lower substrate translocation by hNET than rNET; (2) the aspartate 7 and lysine 62 residues in the N-terminus of hNET determine the higher affinities of substrates for the hNET than the rNET; and (3) the lysine 62 and glutamine 612 residues in the N- and C-termini, respectively, of hNET are determinants of the higher cocaine affinity for the hNET than rNET.

摘要

我们实验室之前的一项研究表明,去甲肾上腺素转运体(NET)物种变体在药理学上的差异,是大鼠NET(rNET)和人类NET(hNET)之间26个不同氨基酸中4个非保守氨基酸交换的结果。本研究的目的是研究将rNET中这四个显著改变局部电荷分布的氨基酸残基,替换为hNET中相应氨基酸后的影响。

利用定点诱变技术从rNET cDNA创建突变cDNA。将突变型NET(rK7D、rE62K、rK375N和rR612Q)、rNET和hNET在瞬时转染的COS-7细胞中表达,以确定这些突变对物种变体不同药理学特性的影响。rNET和rR612Q的去甲肾上腺素摄取V(max)与尼索西汀结合B(max)的比值(这是转运体周转数的一种衡量指标,即每分钟的转运循环数)高于hNET、rK7D、rE62K和rK375N。hNET、rK7D、rE62K和rK375N的去甲肾上腺素K(m)低于rNET或rR612Q。rNET、hNET或突变体对尼索西汀抑制去甲肾上腺素摄取的K(i)值没有差异,但hNET、rE62K和rR612Q的可卡因K(i)值低于rNET或rK375N。

因此,该研究表明:(1)天冬氨酸7、赖氨酸62和天冬酰胺375氨基酸残基对于决定hNET比rNET更低的底物转运很重要;(2)hNET N端的天冬氨酸7和赖氨酸62残基决定了底物对hNET的亲和力高于rNET;(3)hNET N端的赖氨酸62和C端的谷氨酰胺612残基分别是可卡因对hNET亲和力高于rNET的决定因素。

相似文献

1
Amino acids involved in differences in the pharmacological profiles of the rat and human noradrenaline transporters.参与大鼠和人类去甲肾上腺素转运体药理学特性差异的氨基酸。
Naunyn Schmiedebergs Arch Pharmacol. 2002 Apr;365(4):312-7. doi: 10.1007/s00210-002-0528-z. Epub 2002 Feb 20.
2
Investigation of the functional roles of the MELAL and GQXXRXG motifs of the human noradrenaline transporter using cysteine mutants.利用半胱氨酸突变体对人去甲肾上腺素转运体的MELAL和GQXXRXG基序的功能作用进行研究。
Eur J Pharmacol. 2007 Feb 5;556(1-3):27-35. doi: 10.1016/j.ejphar.2006.10.058. Epub 2006 Nov 3.
3
Inhibition of transport function and desipramine binding at the human noradrenaline transporter by N-ethylmaleimide and protection by substrate analogs.N-乙基马来酰亚胺对人去甲肾上腺素转运体转运功能及地昔帕明结合的抑制作用以及底物类似物的保护作用。
Naunyn Schmiedebergs Arch Pharmacol. 2002 Jun;365(6):457-61. doi: 10.1007/s00210-002-0532-3. Epub 2002 Apr 18.
4
Functional importance of the C-terminus of the human norepinephrine transporter.人类去甲肾上腺素转运体C末端的功能重要性。
J Neurochem. 2004 Nov;91(3):537-46. doi: 10.1111/j.1471-4159.2004.02729.x.
5
Roles of transmembrane domain 2 and the first intracellular loop in human noradrenaline transporter function: pharmacological and SCAM analysis.跨膜结构域2和第一个细胞内环在人去甲肾上腺素转运体功能中的作用:药理学和扫描诱变分析。
J Neurochem. 2005 Sep;94(6):1620-30. doi: 10.1111/j.1471-4159.2005.03316.x. Epub 2005 Aug 10.
6
Comparison of the pharmacological properties of cloned rat, human, and bovine norepinephrine transporters.克隆大鼠、人类和牛去甲肾上腺素转运体的药理学特性比较。
J Pharmacol Exp Ther. 1999 Aug;290(2):761-7.
7
Pharmacological properties of the naturally occurring Ala(457)Pro variant of the human norepinephrine transporter.人类去甲肾上腺素转运体天然存在的Ala(457)Pro变体的药理学特性。
Pharmacogenetics. 2002 Mar;12(2):165-73. doi: 10.1097/00008571-200203000-00010.
8
Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition.人去甲肾上腺素转运体无法进行N-糖基化会降低蛋白质稳定性、表面转运和转运活性,但不会影响配体识别。
Mol Pharmacol. 1996 Aug;50(2):266-76.
9
The N-terminus of the norepinephrine transporter regulates the magnitude and selectivity of the transporter-associated leak current.去甲肾上腺素转运体的N端调节转运体相关漏电流的大小和选择性。
Neuropharmacology. 2006 Mar;50(3):354-61. doi: 10.1016/j.neuropharm.2005.09.012. Epub 2005 Nov 14.
10
Tyrosine residue 271 of the norepinephrine transporter is an important determinant of its pharmacology.去甲肾上腺素转运体的酪氨酸残基271是其药理学的重要决定因素。
Brain Res Mol Brain Res. 2001 Dec 16;97(1):32-42. doi: 10.1016/s0169-328x(01)00295-9.